Literature DB >> 1295093

Laryngeal involvement in systemic lupus erythematosus.

A D Teitel1, C R MacKenzie, R Stern, S A Paget.   

Abstract

Laryngeal involvement in systemic lupus erythematosus (SLE) can range from mild ulcerations, vocal cord paralysis, and edema to necrotizing vasculitis with airway obstruction. In this report, four cases showing the range of severity of this disease manifestation are presented, accompanied by a comprehensive review of the literature. The clinical course of 97 patients with laryngeal involvement with SLE are reviewed, of whom 28% had laryngeal edema and 11% had vocal cord paralysis. In the majority of cases, symptoms such as hoarseness, dyspnea, and vocal cord paralysis resolved with corticosteroid therapy. Other, less common causes of this entity included subglottic stenosis, rheumatoid nodules, inflammatory mass lesions, necrotizing vasculitis, and epiglottitis. The clinical presentation of laryngeal involvement in patients with SLE follows a highly variable course, ranging from an asymptomatic state to severe, life-threatening upper airway compromise. With its unpredictable course and multiple causations, this complication remains a diagnostic and therapeutic challenge to physicians involved in the care of patients with SLE.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1295093     DOI: 10.1016/0049-0172(92)90020-e

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  9 in total

1.  Acute epiglottitis as the initial presentation of pediatric Systemic Lupus Erythematosus.

Authors:  Sirirat Charuvanij; Kristin M Houghton
Journal:  Pediatr Rheumatol Online J       Date:  2009-10-31       Impact factor: 3.054

2.  Long-term Surveillance Following Intralesional Steroid Injection for Benign Vocal Fold Lesions.

Authors:  Chi-Te Wang; Mei-Shu Lai; Po-Wen Cheng
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-06-01       Impact factor: 6.223

3.  Vocal cord lesions in representative autoimmune diseases.

Authors:  Xia Meng; Hao Jie Xu; Rong Li Li; Li Dan Zhao
Journal:  Clin Rheumatol       Date:  2022-10-21       Impact factor: 3.650

4.  [Bamboo nodes as the cause of dysphonias in autoimmune diseases].

Authors:  C Schwemmle; M Ptok
Journal:  HNO       Date:  2007-07       Impact factor: 1.330

5.  Voice disorder in systemic lupus erythematosus.

Authors:  Milena S F C de Macedo; Kauê M Costa; Manoel da Silva Filho
Journal:  PLoS One       Date:  2017-04-17       Impact factor: 3.240

6.  Laryngeal manifestations of rheumatoid arthritis.

Authors:  A L Hamdan; D Sarieddine
Journal:  Autoimmune Dis       Date:  2013-06-25

Review 7.  Respiratory Manifestations in Systemic Lupus Erythematosus.

Authors:  Salvatore Di Bartolomeo; Alessia Alunno; Francesco Carubbi
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-18

8.  Laryngeal assessment in rheumatic disease patients.

Authors:  Hugo Valter Lisboa Ramos; Jackeline Pillon; Eduardo M Kosugi; Reginaldo Fujita; Paulo Pontes
Journal:  Braz J Otorhinolaryngol       Date:  2005-12-15

Review 9.  Steroid injection in chronic inflammatory vocal fold disorders, literature review.

Authors:  Andrea Maria Campagnolo; Domingos Hiroshi Tsuji; Luís Ubirajara Sennes; Rui Imamura
Journal:  Braz J Otorhinolaryngol       Date:  2008 Nov-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.